Norway· NO-ID_7CC64712-1F89-418E-8A1C-2C5188957777
Aspaveli
A pegcetacoplan product containing pegcetacoplan, registered in Norway by Apellis Ireland Limited. The same ATC class is registered in 12 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Pegcetacoplan is registered in 12 of 19 countries.
Countries holding a registration under ATC L04AJ03 (pegcetacoplan), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 8 of them publish a price we can compare per daily dose
Pegcetacoplan · ATC L04AJ03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FEST (Norway)- Active substance
- Pegcetacoplan
- Manufacturer
- Apellis Ireland Limited
- Country
- Norway (NO)
- ATC code
- L04AJ03
- ATC class
- Pegcetacoplan
- Defined daily dose
- 0.3 g, P
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 5
2 priced- no_merkevare_idID_7CC64712-1F89-418E-8A1C-2C5188957777
- no_varenummer49840520NOK 40376.9
- no_varenummer5046598 x 20NOK 322761.6
- gtin7350031443349
- gtin7350031443356
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Pegcetacoplan in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaASPAVELISwedish Orphan Biovitrum AB (publ), Stockholm
- BelgiumAspaveli 1080 mgSwedish Orphan Biovitrum (Publ)
- SpainASPAVELI 1080 MG SOLUCION PARA PERFUSIONSwedish Orphan Biovitrum Ab (Publ)
- IcelandASPAVELI*Swedish Orphan Biovitrum AB (publ)
- SwedenASPAVELI 1080 mg Infusionsvätska, lösningSwedish Orphan Biovitrum AB (publ)
- United StatesEmpaveliApellis Pharmaceuticals, Inc.
- SwitzerlandAspaveli
- FinlandASPAVELISwedish Orphan Biovitrum AB (publ)
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Aspaveli
- Liechtenstein · Aspaveli
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1f144dc1-f006-44b3-a904-1fef304b48fb GET /v1/drugs/1f144dc1-f006-44b3-a904-1fef304b48fb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Infusjonsvæske, oppløsning",
"source": "fest",
"status": "A",
"atc_name": "Pegcetakoplan",
"merkevare_id": "ID_7CC64712-1F89-418E-8A1C-2C5188957777",
"name_form_strength": "Aspaveli inf, oppl 1080 mg",
"prescription_group": "C"
}See everything about pegcetacoplan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.